Freeze-dried vaccines explained – new video uploaded to AP Video Hub

A picture of the Bell Tower through some trees.

WEST LAFAYETTE, Ind. —

A video featuring Alina Alexeenko, a professor in the School of Aeronautics and Astronautics and the Davidson School of Chemical Engineering at Purdue University, has been uploaded to the AP Video Hub.

In the video, she explains the history, process and future of freeze-dried vaccines. All videos in the Campus Insights series are free for download and use by all AP members and can be found at apvideohub.ap.org or by doing a general search on the Associated Press site. AP members may use the video or to pull quotes for print article or for broadcast or podcast.

STORYLINE

Alexeenko says that lyophilization, also known as freeze drying, refers to technology that removes water at low temperatures and pressure. This process is used to freeze dry food products such as fruits and vegetables, but lyophilization has applications in the medical field, as well. Alexeenko says that freeze drying vaccines preserves the very sensitive and complex active ingredients for long-term storage and shipping. Vaccines such as those used for COVID-19 would benefit from this process, as they currently must be stored and shipped in expensive refrigerated containers. Freeze-dried vaccines have been used in the past to combat and eradicate smallpox. Alexeenko says that lyophilization requires a vacuum, low temperatures and a sterile environment. As a result, this process is slow and energy intensive. She says that work is being done to make lyophilization faster and more economical for mass production. The freeze drying of new vaccines is an ongoing effort that is important for addressing the current and future pandemics.

Uncategorized News

Manufacturing Day at Purdue features the launch of 3 major manufacturing activities

October 1, 2024

For second year in a row, Purdue ranked among top 50 undergraduate colleges in America by U.S. News & World Report

September 24, 2024

Two Eradivir employees wearing gloves, eye protection and lab coats lean over a table in a lab.

Biotech company Eradivir closes $10.25M Series A funding round to complete Phase 2a study of influenza therapeutic

September 23, 2024

More than 10,000 new Purdue students will participate in on-campus orientation programs in West Lafayette and Indianapolis

August 12, 2024

All Uncategorized News